NDC product
Lisinopril and Hydrochlorothiazide
NDC 68071-2303 · NuCare Pharmaceuticals,Inc.
Key facts
| Product NDC | 68071-2303 |
|---|---|
| Proprietary name | Lisinopril and Hydrochlorothiazide |
| Nonproprietary name | Lisinopril and Hydrochlorothiazide Tablets |
| Substances | LISINOPRIL, HYDROCHLOROTHIAZIDE |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA204058 |
| Pharmacologic classes | Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS] |
| Marketing start | Dec 26, 2019 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: